TRT Dosage Guide: Starting Doses, How Doctors Titrate, and What Actually Works (2026)

Introduction

The question almost every man asks before starting TRT: How much testosterone should I take?

The honest answer is: less than most clinics start you on, more frequently than you probably expect, and the right dose for you won't be obvious until you have labs 6–8 weeks in.

What most men find when they search "TRT dosage" is a number: 100–200mg per week of testosterone cypionate. What they don't find is the context that makes that number meaningful — or meaningless.

This article breaks down:

• Starting doses by delivery method, with the evidence behind them
• The titration process that determines your right dose
• What lab numbers you're actually targeting (not just a dose)
• Why frequency matters as much as the number on the syringe
• The patterns that signal overdosing — which is more common than under-dosing at established clinics
• How to think about dose adjustments when TRT isn't working the way it should

The Problem With "100mg Per Week"

If you've researched TRT, you've likely seen 100mg/week of testosterone cypionate cited as a standard starting dose. For some men, that's correct. For others, it's too high to start — and starting too high makes it harder, not easier, to find your optimal level.

Here's why:

Supraphysiologic peaks create misleading labs. A 100mg/week single injection creates a large peak-trough swing, particularly in the first few days. Labs drawn at the wrong time give you a false read on where you actually are across the week.

High starting doses accelerate side-effect variables. Hematocrit elevation, estradiol (E2) conversion, and potential sleep apnea worsening all scale with dose. Starting lower gives you cleaner signal about how your body responds.

The FDA-approved dosing range is outdated. The FDA label for testosterone cypionate technically reads "50–400mg every 2–4 weeks." That's a 2-week injection schedule developed in the 1970s. Modern TRT practice — based on clinical outcomes and half-life pharmacokinetics — uses weekly or twice-weekly dosing at lower per-injection amounts for more stable levels. The label exists for legal reasons, not clinical best-practice.

The goal is not a dose. The goal is a lab number. TRT dosing is a titration process targeting a testosterone range — typically 500–900 ng/dL total T, with free T in the upper-normal range — not a fixed mg/week number that applies universally.

Starting Doses by Delivery Method

These are the clinically common starting points for men who have confirmed hypogonadism (total T below 300–350 ng/dL, or documented symptoms with borderline labs). They are starting points, not targets — your dose will almost certainly change at the first follow-up.

The most important note on this table: These are starting numbers based on typical clinical practice. Your starting dose should be calibrated to your pre-treatment labs, weight, age, SHBG level, and symptoms — not just picked from a standard range.

What You're Actually Targeting: Lab Numbers, Not Dose Numbers

The correct frame for TRT dosing isn't "I'm taking X mg/week." It's "I'm trying to get my labs into this range."

Total Testosterone Target
Most clinicians and clinical guidelines (Endocrine Society, AUA) aim for 500–900 ng/dL total testosterone in men on TRT. Some men need to be higher in this range to resolve symptoms; others feel optimal at 550–650. The point isn't a specific number — it's finding where you function well, supported by both labs and symptom resolution.

A total T above 1,000–1,100 ng/dL on TRT suggests you are likely overdosed. Above 1,200 ng/dL, you are outside physiologic range and increasing risk without proportional benefit.

Free Testosterone
Free T is often more clinically informative than total T, particularly for men with high SHBG. Target the upper third of the normal range for your lab's reference. If free T is low-normal despite total T being adequate, SHBG management (not dose escalation) is the lever — discussed more below.

Estradiol (E2) — Sensitive LC/MS Assay
Optimal range is roughly 20–40 pg/mL (sensitive assay). E2 will rise as testosterone rises; this is expected and often healthy at moderate levels. The goal is not to suppress E2 — it's to stay in range. Crashed E2 from over-aggressive anastrozole use is a more common problem than high E2 in well-managed TRT patients.

Hematocrit
Monitor at baseline, 6–8 weeks, and every 6–12 months thereafter. Flag at >50%, intervene at >52%. Dose reduction (or frequency increase to reduce peak-trough swing) is the first lever before any phlebotomy discussion.

PSA
Baseline required. Recheck at 6 months, then annually. An increase >1.4 ng/mL above baseline in a 12-month period or a PSA velocity >0.4 ng/mL/year warrants urology referral. This is not a reason to avoid TRT — it is a monitoring standard.

How Titration Actually Works

Good TRT practice is a titration loop, not a "set it and forget it" protocol. Here's how it should unfold:

Baseline labs (before first dose)
Full testosterone panel: total T (morning, twice), free T, SHBG, E2 (sensitive), LH, FSH, CBC (hematocrit baseline), PSA, metabolic panel. If you start without these, you have no baseline to calibrate against.

6–8 week labs
The first real checkpoint. Labs should be drawn at trough (just before your next injection) if you are on once-weekly injections, or at mid-cycle (3–4 days after your injection) if you are on twice-weekly or SubQ. This timing determines whether your result is clinically meaningful.

If total T is:

• Below 400 ng/dL at trough: Dose is likely too low or frequency too infrequent. Consider increasing dose by 10–20% or switching to twice-weekly injections.
• 400–700 ng/dL at trough: Working range. Assess how you feel. Do not adjust if symptomatic improvement is occurring.
• 700–900 ng/dL at trough: High-normal trough. May be appropriate, but watch hematocrit closely.
• Above 900 ng/dL at trough: Likely overdosed. Reduce dose before escalating anything else.

12-week follow-up (symptom + lab reassessment)
By week 12, most of the initial testosterone-related symptom improvement has either materialized or hasn't. If libido, energy, and mood haven't improved despite labs being in range, the cause is likely not the TRT dose. Look for: sleep apnea, crashed E2, thyroid dysfunction, insulin resistance, or psychological factors.

Ongoing monitoring
Once stable, 6-month labs are sufficient for most men. Annual check once you have been at the same dose for 12+ months with stable hematocrit and PSA trajectory.

Frequency Matters as Much as Dose

This is the single most underappreciated point in TRT dosing discussions.

100mg/week as one injection gives you a large peak (often 1,000–1,200+ ng/dL in the first 24–48 hours) followed by a trough at day 7 that may fall to 300–400 ng/dL in men with faster cypionate metabolism. That trough is when you feel bad.

50mg twice per week — the same weekly total — gives you smaller peaks (often 600–800 ng/dL) with a floor that stays in range. Many men who "didn't respond" to once-weekly TRT respond well on twice-weekly dosing at the same or even lower total weekly dose.

SubQ daily or every-other-day (20–30mg) is the most stable delivery for injection-based TRT and is particularly appropriate for men who:

• Have sensitive E2 conversion (aromatize heavily)
• Have experienced hematocrit issues at higher per-injection doses
• Have sleep apnea and want to reduce peak hematocrit driver

The dose-frequency tradeoff is always available as an adjustment lever before changing the total weekly mg.

Why SHBG Changes Your Effective Dose

SHBG (sex hormone-binding globulin) binds testosterone in the blood, making it biologically unavailable. Men with high SHBG require more total T to achieve adequate free T.

High SHBG (above 50–60 nmol/L):
A 100mg/week dose may produce adequate total T (600–700 ng/dL) but low free T. You need to see the free T number — total T alone will look fine, but the active fraction will be low. These men often need higher doses or alternative protocols (enclomiphene to stimulate endogenous production with less SHBG suppression).

Low SHBG (below 20 nmol/L):
Total T clears faster. Men with low SHBG often do better with more frequent, lower per-injection doses (daily or EOD SubQ). Once-weekly injections create wider swings and faster clearance that works against them.

Obesity lowers SHBG, which is why men who lose significant weight (especially on GLP-1 medications) often see their free T normalize even without TRT.

Signs You May Be Overdosed

Clinic marketing rarely discusses this. Overdosing on TRT is more common than most men realize — particularly at commercial online TRT clinics that use flat-rate 200mg/2-week protocols.

Watch for:

• Hematocrit rising above 50% (dose reduction, not donation-first)
• Acne, particularly on the back and chest (E2 + DHT)
• Elevated E2 symptoms (water retention, emotional lability, sensitive nipples) without crashed E2
• Feeling worse after the injection day ("post-injection" anxiety or irritability) — this is a peak-too-high signal
• PSA velocity increasing faster than expected
• Sleep quality worsening despite TRT being on board longer than 12 weeks
• Aggressive or irritable mood, particularly in the first 2–3 days post-injection

None of these symptoms should be managed by adding more medications (anastrozole, DHT blockers) without first considering whether the dose is simply too high.

The 5-Variable Dose Adjustment Framework

When your TRT protocol isn't working, the answer is almost never "more testosterone." Work through these in order:

Only after all five are addressed should you increase total weekly dose.

Oral TRT: Dosing Is Different

Oral testosterone undecanoate (brand names Jatenzo and Kyzatrex, FDA-approved 2019–2022) has a different pharmacokinetic profile than injection-based TRT. It is absorbed via the lymphatic system rather than first-pass liver metabolism, which is why the older oral methyltestosterone formulations caused liver toxicity — this generation does not.

Starting dose for Jatenzo: 237mg twice daily with a high-fat meal (required for absorption).
Starting dose for Kyzatrex: 150–300mg twice daily with food.

Dose adjustments are based on serum T levels drawn 4–6 hours after the morning dose (mid-dose peak measurement, not trough). Target: 400–900 ng/dL at mid-dose.

Key tradeoffs vs. injectable TRT:

• Higher DHT conversion (similar to topical testosterone) — relevant for hair loss and prostate monitoring
• Cost is significantly higher than compounded injectable cypionate ($250–400/month vs. $25–75/month)
• No needles
• Dose adjustment happens at next prescription — you cannot self-adjust between appointments
• Newer class; long-term data (10+ years) is more limited than injection-based TRT

Oral TRT is genuinely appropriate for men who:

• Cannot or will not self-inject
• Have professional or lifestyle reasons to avoid injection stigma
• Have tried gels and are non-responders or have transfer-risk concerns

It is not a clinical upgrade over injectable TRT for men who are comfortable with injections.

Dose Across the Lifespan: Men Over 50

Men starting TRT over 50 (or 60) often have comorbidities that warrant more conservative starting doses.

Lower starting dose rationale:

• Hematocrit rises faster with age (baseline hematocrit already higher in older men)
• Cardiovascular risk factors (AFib, prior cardiac events) are more common — per TRAVERSE trial signal on AFib at pharmacologic doses
• PSA sensitivity increases — a higher baseline warrants more careful monitoring intervals
• SHBG is often higher with age, meaning free T targets become more important than total T numbers

Common starting approach for men 55+: 50–80mg/week or twice-weekly 25–40mg injections. More conservative titration steps (6-week labs before any change). Cardiology co-management if active AFib or prior cardiac events.

This doesn't mean TRT is contraindicated for older men — the TRAVERSE trial showed no increased MACE risk vs. placebo in high-risk cardiovascular men. It means the titration cadence should be slower and the monitoring frequency higher.

FAQ

Q: What is a typical TRT dose per week?
A: The most common starting dose for testosterone cypionate or enanthate injections is 80–100mg per week, divided into once-weekly or twice-weekly injections. Some men do well at 60–80mg/week; others need 120–150mg for adequate levels. The right dose is determined by labs at 6–8 weeks, not by a standard number.

Q: Is 200mg of testosterone per week a lot?
A: For most men on TRT, 200mg/week produces supraphysiologic levels — typically 900–1,400 ng/dL depending on metabolism — which is above the therapeutic target of 500–900 ng/dL. It's not dangerous at that level, but it isn't "more effective" than a dose that produces 700 ng/dL, and the higher dose increases hematocrit and E2 conversion. 200mg/2 weeks (the old FDA label approach) is a separate issue — that's an outdated dosing schedule that produces extreme peak-trough swings.

Q: How do I know if my TRT dose is too low?
A: Check labs at trough (just before your next injection). If total T is below 400 ng/dL at trough and you still have symptoms, the dose or frequency may need adjustment. But rule out lab timing errors, E2 problems, sleep apnea, and thyroid issues before concluding the dose is the problem.

Q: Can I start at a lower dose and work up?
A: Yes, and for many men this is the better approach. Starting at 50–70mg/week, checking labs at 6–8 weeks, and adjusting upward if needed gives you cleaner signal and reduces the chance of overdosing in the first cycle. The downside is a slightly longer ramp-up period before you hit your target range.

Q: What's the difference between twice-weekly and once-weekly TRT injections at the same total dose?
A: Twice-weekly injections produce lower peaks, higher troughs, and more stable serum testosterone throughout the week. Many men who felt inconsistent on once-weekly TRT respond much better to the same weekly total split into two injections. For SubQ dosing, some men prefer daily or every-other-day micro-doses for maximum stability.

Q: Does body weight affect TRT dosage?
A: Indirectly, yes. Higher body fat increases aromatase activity, which converts more testosterone to estradiol. Men with more body fat may need tighter E2 monitoring and may see more rapid hematocrit rise at a given dose. SHBG is also lower in men with obesity, which increases testosterone clearance and may require more frequent dosing.

Q: How long does it take to find the right TRT dose?
A: Most men have a working dose by the 12-week mark with two titration windows (6-week labs + 12-week labs). Some men need 6 months of adjustment, particularly if SHBG, E2, or sleep apnea variables are in play. Patience during titration is part of the process — labs reflect steady state at approximately 5–6 weeks after any dose change.

Q: Should I take the same dose forever?
A: Not necessarily. Body composition changes, weight loss, aging, and protocol changes can all shift your optimal dose. Most stable TRT patients land at a consistent dose for years, but annual labs and symptom check-ins are important. Some men who lose significant weight (especially post-GLP-1) see their endogenous production recover enough to reduce TRT dose.

Image Concepts

Image 1 — OG / Hero Card

Concept: Clean split-panel graphic. Left side: large syringe labeled "200mg/2 weeks" (crossed out, labeled "outdated") with a flat red line (peak-trough spike). Right side: syringe labeled "80mg/week" with a smooth level stability curve in blue.
Text overlay: "More isn't better. Stable is better."
Alt text: "Comparison of outdated TRT dosing (200mg every 2 weeks) vs modern protocol (80mg weekly) showing level stability curve"
Palette: Deep navy background, white typography, muted blue stability curve

Image 2 — Lab Target Zones Chart

Concept: Horizontal bar chart showing testosterone level zones.
Zones:

• Red (overdosed): >1,000 ng/dL
• Green (therapeutic target): 500–900 ng/dL
• Yellow (low therapeutic): 300–500 ng/dL
• Red (insufficient): <300 ng/dL

Add secondary small bar below showing E2 target zones (10–20 pg/mL = crash risk, 20–40 pg/mL = optimal, 40–60 pg/mL = elevated, >60 pg/mL = manage).
Alt text: "TRT testosterone and estradiol lab target zones chart"

Image 3 — Frequency Comparison Visual

Concept: Two-panel timeline chart over 7 days.
Panel A: "Once-weekly injection" — steep peak on Day 1 dropping to trough by Day 6–7. Label trough as "feels bad zone."
Panel B: "Twice-weekly injection (same total dose)" — two smaller peaks with a stable floor throughout the week. Label range as "stays in therapeutic range."
Text overlay: "Same weekly dose. Very different experience."
Alt text: "Comparison of once-weekly vs twice-weekly TRT injection level stability over 7 days"